European Journal of Ultrasound

Read UiM/EJU offline

UiM/EJU subscribers are now provided with a mobile digital issue of their journal. The eRef app enables you to comfortably read the latest journal issues on your tablet.

Find out more about the eRef app here

Use UiM/EJU offline • optimal reading experience • scalable font size • one click to download UiM/EJU

Ultrasound International Open

New open-access journal!

For author instructions and further information about publishing in UIO, visit

Impact Factor 2016

The Impact Factor 2016 for the EJU is 3.892



30th Euroson Congress of the EFSUMB

The next EUROSON meeting will take place this year in Poznan, Poland from the 6 – 9 September in conjunction with the Polish Society. Preparations are well advanced with a lively program scheduled in the delightful setting of the charming city of Poznan. This year there is an ultra-early registration fee set at a very reasonable cost; look on the website and book now to take advantage of this extremely generous registration fee. We welcome as many as possible of the EFSUMB members to join us for the education and, of course, meeting old and new friends.

Read more »



Bericht zur DEGUM-Pressekonferenz am 12. Dezember 2018 in Berlin

Bei vielen Untersuchungen ist die Ultraschalldiagnostik die Methode der Wahl. Eine wichtige Voraussetzung für ein treffsicheres Ergebnis ist jedoch die Qualifikation des untersuchenden Arztes. Diese ist aber nicht immer ausreichend vorhanden: So wird beispielsweise bei Routineschwangerschaftsuntersuchungen nur ein Drittel aller Herzfehler bei Ungeborenen erkannt. Mit Blick auf die aktuelle Novellierung der (Muster-)Weiterbildungsordnung für Ärzte forderten Experten der DEGUM deshalb auf einer Pressekonferenz in Berlin klare Qualitätsrichtlinien für die Ultraschalldiagnostik.

Lesen Sie mehr »


More Information »

More information on all EUROSON Schools can be found on >>

Copyright, Ethics, Product Liability


Submission of a manuscript to Ultraschall in der Medizin / European Journal of Ultrasound implies that it represents original research not previously published and that it is not being considered for publication elsewhere (see Guidelines for Authors). The corresponding author declares that the manuscript is submitted on behalf of all authors.

If your manuscript submitted to Ultraschall in der Medizin / European Journal of Ultrasound successfully passes the peer review, and is accepted by the editors of the journal, Thieme publishers acquire for the duration of the legal period of protection the exclusive right for the use of the rights of exploitation according to copyright laws, especially also the rights of translation, of publication in special issues, the use of individual passages of text for use in schools, the use for electronic text and visual image communication (also on-line, Internet), use in radio or television programmes, production of microcopies, renting or leasing for a fee or payment, duplication by photomechanical or similar means, storage in electronic databases as well as any other virtual storage and retrieval therefrom, in addition to any processing that may be necessary for the exploitation of the above-mentioned rights. Insofar as the above-mentioned rights are managed by an exploitation company the publisher is entitled to enter into the necessary contracts with the relevant exploitation companies; the publisher is also empowered to enter into contracts with third parties for the exploitation of these rights


With the submission of the manuscript to Ultraschall in der Medizin / European Journal of Ultrasound you as the author confirm that all research involving intervention in human subjects or animals has received the approval of the institutional ethics commitee. If the institution has no formal ethics commitee, you confirm that the terms of the latest version of the Declaration of Helsinki for Medical Research involving Human Subjects have been adhered, and that experiments involving animals adhered to ethical standards.

Product Liability

Product liability laws place a heavy responsibility on you as the author of a scientific publication. This is especially the case when you report on therapeutic modalities and/or drug doses. Thus, please check these details in your manuscript very carefully. Depending on the degree of the theoretically possible dangers, please ask an experienced colleague or co-worker to also check on these details. During the editorial processing of your manuscript by the publisher it will be proof-read several times and, for example, details of doses carefully checked; however, only you as the author have the necessary specialist knowledge to assess the appropriateness of these details. The responsibility for their correctness lies exclusively with you as the author. Together with our authors we want to reduce the risk of possible injury to patients as well of damage claims and liability proceedings. For this we depend on your cooperation.